chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Breast tenderness, Lymphadenopathy
Clinical narrative: The pain went across to my left breast  and it was tender to the touch; Under left arm, the armpit, pain and swelling; Swelling in armpit; pain across to my left breast; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (pain across to my left breast), BREAST TENDERNESS (The pain went across to my left breast  and it was tender to the touch), AXILLARY PAIN (Under left arm, the armpit, pain and swelling) and LYMPHADENOPATHY (Swelling in armpit) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939903, 031L20A and 027A21A) for COVID-19 vaccination.     No Medical history information was reported.  Concomitant products included ATORVASTATIN CALCIUM (ATORVASTATIN +PHARMA) for Cholesterol, LEVOTHYROXINE for Thyroxine, VITAMIN D NOS, VITAMIN E NOS, ASCORBIC ACID (VITAMIN C ACID) and ACETYLSALICYLIC ACID (ASPIRIN ACTAVIS) for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, the patient experienced BREAST PAIN (pain across to my left breast), AXILLARY PAIN (Under left arm, the armpit, pain and swelling) and LYMPHADENOPATHY (Swelling in armpit). On 29-Oct-2021, the patient experienced BREAST TENDERNESS (The pain went across to my left breast  and it was tender to the touch). The patient was treated with PARACETAMOL (TYLENOL A) for Adverse event, at an unspecified dose and frequency. On 03-Nov-2021, AXILLARY PAIN (Under left arm, the armpit, pain and swelling) and LYMPHADENOPATHY (Swelling in armpit) had resolved. At the time of the report, BREAST PAIN (pain across to my left breast) had not resolved and BREAST TENDERNESS (The pain went across to my left breast  and it was tender to the touch) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient new event include  pain went across to my left breast  and it was tender to the touch and outcome of the event is not recovered or resolved.   This case was linked to MOD-2021-370048 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Nov-2021: Significant Follow up event added and Under left arm, the armpit, pain and swelling event outcome was updated and  patient demographic details added.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a booster dose from a vial that was punctured more than 12 hours before; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a booster dose from a vial that was punctured more than 12 hours before) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a booster dose from a vial that was punctured more than 12 hours before). On 01-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Patient received a booster dose from a vial that was punctured more than 12 hours before) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was reported.  It was reported that the vial was initially stored in refrigerator on 29 Oct 2021 and vial was punctured on at 08:45 am and didn't undergo temperature excursion. The vial was exposed to room temperature range (8 to 25 degree Celsius/ 46  to 77 degree Fahrenheit) only while being drawn up.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Pain in extremity, Peripheral swelling, Rhinorrhoea
Clinical narrative: arm pain; diarrhea non-stop; nose has been running almost non-stop; loss of appetite; Swelling in arm with pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), DIARRHOEA (diarrhea non-stop), RHINORRHOEA (nose has been running almost non-stop), DECREASED APPETITE (loss of appetite) and PERIPHERAL SWELLING (Swelling in arm with pain) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included Bypass surgery. Concurrent medical conditions included Cancer.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), DIARRHOEA (diarrhea non-stop), RHINORRHOEA (nose has been running almost non-stop), DECREASED APPETITE (loss of appetite) and PERIPHERAL SWELLING (Swelling in arm with pain). At the time of the report, PAIN IN EXTREMITY (arm pain), DIARRHOEA (diarrhea non-stop), RHINORRHOEA (nose has been running almost non-stop), DECREASED APPETITE (loss of appetite) and PERIPHERAL SWELLING (Swelling in arm with pain) outcome was unknown.            Patient claimed to have had 7 surgeries in a row, and has "no memory." He took 20 pills a day as regular medication  No concomitant information was provided. No treatment information was provided.   This case was linked to MOD-2021-370097 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received vaccine on 29Oct2021 with an expiration date of 11Oct2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine on 29Oct2021 with an expiration date of 11Oct2021) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037k20a and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 29-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine on 29Oct2021 with an expiration date of 11Oct2021). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Received vaccine on 29Oct2021 with an expiration date of 11Oct2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant product use was reported. No treatment information was provided.   This case was linked to MOD-2021-370033 (E2B Linked Report).; Sender's Comments:  MOD-2021-370033:MOD21-159552 (Original Crosslinked Case)
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore right arm injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore right arm injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore right arm injection site). At the time of the report, VACCINATION SITE PAIN (Sore right arm injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received second Moderna COVID-19 vaccine on 14 Feb 2021 (lot number 006M20A).No Adverse reactions in her left arm. No Concomitant medication was reported.  No treatment medications were reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Mammogram, Peripheral swelling, Product dose omission issue, Ultrasound scan
Clinical narrative: Missed dose; started on the other arm; soreness on the same site of the shot; Lot of tiredness; Swelling arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (started on the other arm), VACCINATION SITE PAIN (soreness on the same site of the shot), FATIGUE (Lot of tiredness), PERIPHERAL SWELLING (Swelling arm) and PRODUCT DOSE OMISSION ISSUE (Missed dose) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE PAIN (soreness on the same site of the shot), FATIGUE (Lot of tiredness) and PERIPHERAL SWELLING (Swelling arm). In April 2021, the patient experienced PERIPHERAL SWELLING (started on the other arm). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose). At the time of the report, PERIPHERAL SWELLING (started on the other arm) had not resolved, VACCINATION SITE PAIN (soreness on the same site of the shot) and FATIGUE (Lot of tiredness) outcome was unknown and PERIPHERAL SWELLING (Swelling arm) and PRODUCT DOSE OMISSION ISSUE (Missed dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Mammogram: normal (normal) Nothing came up and swelling was from the shot as it didn't involve lymph nodes.. In April 2021, Ultrasound scan: normal (normal) Nothing came up and swelling was from the shot as it didn't involve lymph nodes..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Missed dose; started on the other arm; soreness on the same site of the shot; Lot of tiredness; Swelling arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (started on the other arm), VACCINATION SITE PAIN (soreness on the same site of the shot), FATIGUE (Lot of tiredness), PERIPHERAL SWELLING (Swelling arm) and PRODUCT DOSE OMISSION ISSUE (Missed dose) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE PAIN (soreness on the same site of the shot), FATIGUE (Lot of tiredness) and PERIPHERAL SWELLING (Swelling arm). In April 2021, the patient experienced PERIPHERAL SWELLING (started on the other arm). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose). At the time of the report, PERIPHERAL SWELLING (started on the other arm) had not resolved, VACCINATION SITE PAIN (soreness on the same site of the shot) and FATIGUE (Lot of tiredness) outcome was unknown and PERIPHERAL SWELLING (Swelling arm) and PRODUCT DOSE OMISSION ISSUE (Missed dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Mammogram: normal (normal) Nothing came up and swelling was from the shot as it didn't involve lymph nodes.. In April 2021, Ultrasound scan: normal (normal) Nothing came up and swelling was from the shot as it didn't involve lymph nodes..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Gastrooesophageal reflux disease, Malaise, Stress
Clinical narrative: stress and anxiety; acid reflux; stress and anxiety; felt ill; This spontaneous case was reported by a consumer and describes the occurrence of STRESS (stress and anxiety), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), ANXIETY (stress and anxiety) and MALAISE (felt ill) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A212) for COVID-19 vaccination.     Family history included Cardiac disorder (history of cardiac issues with her dad and uncle.) since an unknown date.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced STRESS (stress and anxiety), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), ANXIETY (stress and anxiety) and MALAISE (felt ill). At the time of the report, STRESS (stress and anxiety), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), ANXIETY (stress and anxiety) and MALAISE (felt ill) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.  Acid reflux medication was given as treatment for acid reflux Around thanksgiving last year she got sick, but never had a laboratory COVID-19 test.   This case was linked to MOD-2021-370134 (Patient Link).
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster dose administered one month early/Patient was administered the booster dose after 5 months; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose administered one month early/Patient was administered the booster dose after 5 months) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose administered one month early/Patient was administered the booster dose after 5 months). On 01-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose administered one month early/Patient was administered the booster dose after 5 months) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.  Treatment information was not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site swelling
Clinical narrative: Very bad swollen left arm; Mild side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Very bad swollen left arm) and VACCINATION COMPLICATION (Mild side effects) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Arrhythmia, Cholesterol, Anxiety, Lung cancer and Immunocompromised. Concomitant products included DIAZEPAM (DIAZEPAM ABC) for Anxiety, METOPROLOL TARTRATE for Arrhythmia, ATORVASTATIN for Cholesterol total abnormal NOS, ALBUTEROL SULFATE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Very bad swollen left arm) and VACCINATION COMPLICATION (Mild side effects). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (Very bad swollen left arm) and VACCINATION COMPLICATION (Mild side effects) outcome was unknown.            Treatment medication also included Ice packs   This case was linked to MOD-2021-370233 (Patient Link).
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Inappropriate schedule of product administration
Clinical narrative: Patient received vaccine after expiry date; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: PFIZER BIONTECH COVID-19 VACCINE on 30-Mar-2021 and PFIZER BIONTECH COVID-19 VACCINE.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore right injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore right injection site arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01120A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (sore right injection site arm). At the time of the report, VACCINATION SITE PAIN (sore right injection site arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided. No treatment medications were provided.   This case was linked to MOD-2021-370523 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine past its expiration date administered to 11 patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine past its expiration date administered to 11 patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine past its expiration date administered to 11 patients). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (vaccine past its expiration date administered to 11 patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided. On 29 OCT 2021, one first dose was given to a patient which had expiry date on 27 OCT 2021.   This case was linked to MOD-2021-371244, MOD-2021-371236 (Patient Link).
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: Left arm was itchy; Top of arm 4 inch down was red, hot and had a hard lump; covid arm; Top of arm 4 inch down was red, hot and had a hard lump; Top of left arm 4 inch down was red, hot and had a hard lump; Slight fever of 98.4-98.6; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Left arm was itchy), AXILLARY MASS (Top of arm 4 inch down was red, hot and had a hard lump), VACCINATION SITE REACTION (covid arm), FEELING HOT (Top of arm 4 inch down was red, hot and had a hard lump) and ERYTHEMA (Top of left arm 4 inch down was red, hot and had a hard lump) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included AFib in 2019. Previously administered products included for Product used for unknown indication: Flu shot in October 2021. Past adverse reactions to the above products included No adverse event with Flu shot. Concurrent medical conditions included Cancer. Concomitant products included APIXABAN (ELIQUIS), DILTIAZEM and LEVOTHYROXINE for an unknown indication.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 29-Oct-2021, the patient experienced PRURITUS (Left arm was itchy), AXILLARY MASS (Top of arm 4 inch down was red, hot and had a hard lump), VACCINATION SITE REACTION (covid arm), FEELING HOT (Top of arm 4 inch down was red, hot and had a hard lump), ERYTHEMA (Top of left arm 4 inch down was red, hot and had a hard lump) and PYREXIA (Slight fever of 98.4-98.6). On 31-Oct-2021, PYREXIA (Slight fever of 98.4-98.6) had resolved. On 01-Nov-2021, ERYTHEMA (Top of left arm 4 inch down was red, hot and had a hard lump) had resolved. At the time of the report, PRURITUS (Left arm was itchy), AXILLARY MASS (Top of arm 4 inch down was red, hot and had a hard lump), VACCINATION SITE REACTION (covid arm) and FEELING HOT (Top of arm 4 inch down was red, hot and had a hard lump) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Oct-2021, Body temperature: 98.4-98.6 (Low) slight fever of 98.4-98.6.         No treatment medication was reported.   This case was linked to MOD-2021-370414 (Patient Link).
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction, Vaccination site warmth
Clinical narrative: Left arm was itchy; Top of arm 4 inch down was red, hot and had a hard lump; covid arm; Top of arm 4 inch down was red, hot and had a hard lump; Top of left arm 4 inch down was red, hot and had a hard lump; Slight fever of 98.4-98.6; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Left arm was itchy), AXILLARY MASS (Top of arm 4 inch down was red, hot and had a hard lump), VACCINATION SITE REACTION (covid arm), FEELING HOT (Top of arm 4 inch down was red, hot and had a hard lump) and ERYTHEMA (Top of left arm 4 inch down was red, hot and had a hard lump) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included AFib in 2019. Previously administered products included for Product used for unknown indication: Flu shot in October 2021. Past adverse reactions to the above products included No adverse event with Flu shot. Concurrent medical conditions included Cancer. Concomitant products included APIXABAN (ELIQUIS), DILTIAZEM and LEVOTHYROXINE for an unknown indication.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 29-Oct-2021, the patient experienced PRURITUS (Left arm was itchy), AXILLARY MASS (Top of arm 4 inch down was red, hot and had a hard lump), VACCINATION SITE REACTION (covid arm), FEELING HOT (Top of arm 4 inch down was red, hot and had a hard lump), ERYTHEMA (Top of left arm 4 inch down was red, hot and had a hard lump) and PYREXIA (Slight fever of 98.4-98.6). On 31-Oct-2021, PYREXIA (Slight fever of 98.4-98.6) had resolved. On 01-Nov-2021, ERYTHEMA (Top of left arm 4 inch down was red, hot and had a hard lump) had resolved. At the time of the report, PRURITUS (Left arm was itchy), AXILLARY MASS (Top of arm 4 inch down was red, hot and had a hard lump), VACCINATION SITE REACTION (covid arm) and FEELING HOT (Top of arm 4 inch down was red, hot and had a hard lump) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Oct-2021, Body temperature: 98.4-98.6 (Low) slight fever of 98.4-98.6.         No treatment medication was reported.   This case was linked to MOD-2021-370414 (Patient Link).
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Migraine, Pain in extremity, Pyrexia, Vertigo
Clinical narrative: Vertigo; Migaine; Super dizzy; Arm was really sore; Migraine; Lightheadedness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), MIGRAINE (Migaine), DIZZINESS (Super dizzy), PAIN IN EXTREMITY (Arm was really sore) and MIGRAINE (Migraine) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included GABAPENTIN and MELATONIN for an unknown indication.   On 29-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Oct-2021, the patient experienced PAIN IN EXTREMITY (Arm was really sore), MIGRAINE (Migraine), DIZZINESS (Lightheadedness) and PYREXIA (Fever). On 31-Oct-2021, the patient experienced VERTIGO (Vertigo), MIGRAINE (Migaine) and DIZZINESS (Super dizzy). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at a dose of 1 dosage form. On 30-Oct-2021, PAIN IN EXTREMITY (Arm was really sore), MIGRAINE (Migraine), DIZZINESS (Lightheadedness) and PYREXIA (Fever) had resolved. At the time of the report, VERTIGO (Vertigo), MIGRAINE (Migaine) and DIZZINESS (Super dizzy) had not resolved.       This case was linked to MOD-2021-370388 (Patient Link).
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness
Clinical narrative: Very mild tiredness; Felt like he had tiny bit of flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like he had tiny bit of flu-like symptoms) and FATIGUE (Very mild tiredness) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included Premature ventricular contractions (Caffeine related.).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like he had tiny bit of flu-like symptoms) and FATIGUE (Very mild tiredness). On 23-Jan-2021, INFLUENZA LIKE ILLNESS (Felt like he had tiny bit of flu-like symptoms) and FATIGUE (Very mild tiredness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The  concomitant medications on use were not provided. No treatment information was provided.   This case was linked to MOD-2021-370446 (Patient Link).
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in jaw, Vaccination site pain
Clinical narrative: discomfort at his jaw line from the bottom of left ear downward/tissue inside his jaw hurt when you pushed on it; left arm was sore (attempted to rise it); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Nov-2021 and was forwarded to Moderna on 01-Nov-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (discomfort at his jaw line from the bottom of left ear downward/tissue inside his jaw hurt when you pushed on it) and VACCINATION SITE PAIN (left arm was sore (attempted to rise it)) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011O21A) for COVID-19 vaccination.     Concomitant products included INFLUENZA VACCINE (FLU SYRINGE) for an unknown indication.    On 22-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PAIN IN JAW (discomfort at his jaw line from the bottom of left ear downward/tissue inside his jaw hurt when you pushed on it) and VACCINATION SITE PAIN (left arm was sore (attempted to rise it)). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency. In 2021, VACCINATION SITE PAIN (left arm was sore (attempted to rise it)) had resolved. At the time of the report, PAIN IN JAW (discomfort at his jaw line from the bottom of left ear downward/tissue inside his jaw hurt when you pushed on it) had not resolved.            Treatment details also included ICE for adverse event. Patient reported that there was discomfort at his jaw line from the bottom of left ear downward. He described it as the tissue inside his jaw hurt when you pushed on it. The pain is not overwhelming but it is there ~ 10 days later.   This case was linked to MOD-2021-370502 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Illness
Clinical narrative: pretty sick from the last vaccine; worse after second dose, felt bad; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (pretty sick from the last vaccine) and FEELING ABNORMAL (worse after second dose, felt bad) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 095A21A and 089A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (pretty sick from the last vaccine) and FEELING ABNORMAL (worse after second dose, felt bad). At the time of the report, ILLNESS (pretty sick from the last vaccine) and FEELING ABNORMAL (worse after second dose, felt bad) outcome was unknown.            No concomitant medications were provided. No treatment medications were provided.   This case was linked to MOD-2021-370435, MOD-2021-370409, MOD-2021-370422 (Patient Link).
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine after expiry date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product was provided by the reporter. On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. No treatment medication was provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Bad reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Bad reaction) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Bad reaction). At the time of the report, VACCINATION COMPLICATION (Bad reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment medication was provided.   This case was linked to MOD-2021-370484, MOD-2021-370485 (Patient Link).
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: minor pain in the arm when pressed on it; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (minor pain in the arm when pressed on it) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (minor pain in the arm when pressed on it). The patient was treated with ACETAMINOPHEN for Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (minor pain in the arm when pressed on it) outcome was unknown.            Concomitant medications was not specified.  Treatment information also included use of ICE.   This case was linked to MOD-2021-370431 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Pyrexia
Clinical narrative: Really sick; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Really sick), PYREXIA (Fever) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Really sick), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, ILLNESS (Really sick), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            No Concomitant medication information was reported. No Treatment medications were provided  the patient  had reported 2nd dose: 04Mar2021, right arm, IM injection: Lot#: 031M20A Expiration: Unknown Booster do se: 01Nov2021 received
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination complication
Clinical narrative: slight fever, not really high; felt bad/did not feel good for a day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt bad/did not feel good for a day) and PYREXIA (slight fever, not really high) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020 and COVID-19 pneumonia (a mild case). Concurrent medical conditions included Adrenoleukodystrophy (rare disease called leukodystrophy adrenomyeloneuropathy (AMN), which defined as long fatty acids attacking myeloid sheath, damaging it similar to what happens in sclerosis. It is a long progression disease) and Walker user (walks around with a walker).    On 28-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (felt bad/did not feel good for a day) and PYREXIA (slight fever, not really high). At the time of the report, VACCINATION COMPLICATION (felt bad/did not feel good for a day) had resolved and PYREXIA (slight fever, not really high) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-370698, MOD-2021-370729 (Patient Link).
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine after expiry date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. No treatment medication reported by reporter
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received the booster shot on 30OCT2021; The expiration date for booster is Oct 11, 2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the booster shot on 30OCT2021; The expiration date for booster is Oct 11, 2021) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the booster shot on 30OCT2021; The expiration date for booster is Oct 11, 2021). On 30-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient received the booster shot on 30OCT2021; The expiration date for booster is Oct 11, 2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received a booster dose that was outside of the 12 hour window; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a booster dose that was outside of the 12 hour window) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a booster dose that was outside of the 12 hour window). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a booster dose that was outside of the 12 hour window) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered with an expired vaccine /receiving a dose from an expired vial; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with an expired vaccine /receiving a dose from an expired vial) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A, 032L20A and 025L20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Fluad 65+ (Dose number 1) on 20-Oct-2021. Past adverse reactions to the above products included No adverse event with Fluad 65+. Concomitant products included LOSARTAN, FLECAINIDE and RIVAROXABAN (XARELTO) for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 ml. On 05-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with an expired vaccine /receiving a dose from an expired vial). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (administered with an expired vaccine /receiving a dose from an expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient's concomitant medications included Atrial Fibrillation medication  It was also stated that there were no adverse events experienced till date  Treatment information was not reported   This case was linked to MOD-2021-377205 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Nov-2021: Significant follow-up contains dose and route of administration, anatomical site of injection for vaccine On 08-Nov-2021: Follow-up received contains Non significant information. On 08-Nov-2021: Follow up received contained: Updated Address of the reporter, Patient demographics - Race and Ethnicity, Historical vaccine information, Concomitant medication information;
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Received a 2nd dose of 0.25mL instead of 0.5mL; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Received a 2nd dose of 0.25mL instead of 0.5mL) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939904 and 039D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 ml. On 05-Nov-2021, the patient experienced ACCIDENTAL UNDERDOSE (Received a 2nd dose of 0.25mL instead of 0.5mL). On 05-Nov-2021, ACCIDENTAL UNDERDOSE (Received a 2nd dose of 0.25mL instead of 0.5mL) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2021: Significant follow up(batch number, patient's age and race information have been updated)
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Dyspnoea, Gait inability, Mobility decreased
Clinical narrative: chest pain; dizziness; "feel like I am going to stop breathing"/short of breath/I can't breath; "I can't walk"; feel like I'm going to faint; I can't stand up; excruciating pain,intolerable pain; body pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN, DIZZINESS, DYSPNOEA, GAIT INABILITY, and PRESYNCOPE in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Head injury in October 2021 and COVID-19 in November 2020. Concurrent medical conditions included Atrial fibrillation, Heart murmur, Blood pressure high and Chest pain.   In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced CHEST PAIN, DIZZINESS, DYSPNOEA, GAIT INABILITY, PRESYNCOPE, MOBILITY DECREASED, PAIN, and MYALGIA. At the time of the report, CHEST PAIN, DIZZINESS, DYSPNOEA, and GAIT INABILITY had not resolved and PRESYNCOPE, MOBILITY DECREASED, PAIN, and MYALGIA outcome was unknown.            Treatment medications included Pain pill. Concomitant medications included Blood pressure medication, Water pill, and Something to go to the bathroom. Patient does not have history of myocarditis and pericarditis. Patient said that had chest pain normally but now has 3 times the usual chest pain. The symptoms started 1.5 hours after booster dose was given.   This case was linked to MOD-2021-048169 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes on 08-Nov-2021 the Follow up received on 08-Nov-2021 included addition of new events extreme side effects, body pain, I can't stand up, feel like I'm going to faint, excruciating pain, and intolerable pain.